Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

26 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Innovation in the pharmaceutical industry: New estimates of R&D costs.
DiMasi JA, Grabowski HG, Hansen RW. DiMasi JA, et al. Among authors: grabowski hg. J Health Econ. 2016 May;47:20-33. doi: 10.1016/j.jhealeco.2016.01.012. Epub 2016 Feb 12. J Health Econ. 2016. PMID: 26928437
Should the patent system for new medicines be abolished?
DiMasi JA, Grabowski HG. DiMasi JA, et al. Among authors: grabowski hg. Clin Pharmacol Ther. 2007 Nov;82(5):488-90. doi: 10.1038/sj.clpt.6100393. Clin Pharmacol Ther. 2007. PMID: 17952100 No abstract available.
Cost of innovation in the pharmaceutical industry.
DiMasi JA, Hansen RW, Grabowski HG, Lasagna L. DiMasi JA, et al. Among authors: grabowski hg. J Health Econ. 1991 Jul;10(2):107-42. doi: 10.1016/0167-6296(91)90001-4. J Health Econ. 1991. PMID: 10113009
Returns to R&D on new drug introductions in the 1980s.
Grabowski HG, Vernon JM. Grabowski HG, et al. J Health Econ. 1994 Dec;13(4):383-406. doi: 10.1016/0167-6296(94)90010-8. J Health Econ. 1994. PMID: 10140531 Review.
Public policy and pharmaceutical innovation.
Grabowski HG. Grabowski HG. Health Care Financ Rev. 1982 Sep;4(1):75-87. Health Care Financ Rev. 1982. PMID: 10309721 Free PMC article.
The distribution of sales revenues from pharmaceutical innovation.
Grabowski HG, Vernon J. Grabowski HG, et al. Pharmacoeconomics. 2000;18 Suppl 1:21-32. doi: 10.2165/00019053-200018001-00005. Pharmacoeconomics. 2000. PMID: 11151306
Research and development costs for new drugs by therapeutic category. A study of the US pharmaceutical industry.
DiMasi JA, Hansen RW, Grabowski HG, Lasagna L. DiMasi JA, et al. Among authors: grabowski hg. Pharmacoeconomics. 1995 Feb;7(2):152-69. doi: 10.2165/00019053-199507020-00007. Pharmacoeconomics. 1995. PMID: 10155302
The effect of pharmacoeconomics on company research and development decisions.
Grabowski H. Grabowski H. Pharmacoeconomics. 1997 May;11(5):389-97. doi: 10.2165/00019053-199711050-00002. Pharmacoeconomics. 1997. PMID: 10168028 Review.
Updated trends in US brand-name and generic drug competition.
Grabowski H, Long G, Mortimer R, Boyo A. Grabowski H, et al. J Med Econ. 2016 Sep;19(9):836-44. doi: 10.1080/13696998.2016.1176578. Epub 2016 Apr 20. J Med Econ. 2016. PMID: 27064194
Recent trends in brand-name and generic drug competition.
Grabowski H, Long G, Mortimer R. Grabowski H, et al. J Med Econ. 2014 Mar;17(3):207-14. doi: 10.3111/13696998.2013.873723. Epub 2013 Dec 23. J Med Econ. 2014. PMID: 24320785
26 results
Jump to page
Feedback